ERBB2 and neoplasm: Compared to MKN45 cells, the tumor cell viabilities were significantly decreased by lower concentrations of afatinib (10 ng/ml-10 μg/ml) in HER2-overexpressed HCT-15 and AGS cells (Figure 2B).